tiprankstipranks
Advertisement
Advertisement

PCCAGEN Stock Latest News

Cagent Vascular Highlights Serration Remodeling Therapy and Clinical Adoption in Weekly Update
Private CompaniesCagent Vascular Highlights Serration Remodeling Therapy and Clinical Adoption in Weekly Update
21h ago
CAGEN
Peripheral Arterial Disease Therapy Positioning at Cagent Vascular
PremiumPrivate Companies
Peripheral Arterial Disease Therapy Positioning at Cagent Vascular
1d ago
CAGEN
Educational Event Underscores Cagent Vascular’s Focus on PAD Therapy Versatility
PremiumPrivate Companies
Educational Event Underscores Cagent Vascular’s Focus on PAD Therapy Versatility
2d ago
CAGEN
Clinical Use Case Underscores Cagent Vascular’s Peripheral Artery Disease Focus
PremiumPrivate Companies
Clinical Use Case Underscores Cagent Vascular’s Peripheral Artery Disease Focus
3d ago
CAGEN
Vascular Device Firm Highlights Serration-Based Therapy for Complex PAD
PremiumPrivate Companies
Vascular Device Firm Highlights Serration-Based Therapy for Complex PAD
5d ago
CAGEN
Cagent Vascular Inc – Weekly Recap
PremiumPrivate CompaniesCagent Vascular Inc – Weekly Recap
8d ago
CAGEN
Educational Webinar Underscores Cagent Vascular’s Focus on PAD Treatment Innovation
Premium
Private Companies
Educational Webinar Underscores Cagent Vascular’s Focus on PAD Treatment Innovation
9d ago
CAGEN
Peripheral Artery Case Study Underscores Cagent Vascular’s Serranator Utilization
Premium
Private Companies
Peripheral Artery Case Study Underscores Cagent Vascular’s Serranator Utilization
10d ago
CAGEN
Cagent Vascular Highlights Serration Remodeling Therapy at Amputation Prevention Symposium
PremiumPrivate Companies
Cagent Vascular Highlights Serration Remodeling Therapy at Amputation Prevention Symposium
11d ago
CAGEN
Cagent Vascular Highlights Clinical Metrics for Serranator Angioplasty Technology
PremiumPrivate Companies
Cagent Vascular Highlights Clinical Metrics for Serranator Angioplasty Technology
12d ago
CAGEN
Cagent Vascular Highlights Clinical Data and Physician Engagement for Serranator Platform
PremiumPrivate Companies
Cagent Vascular Highlights Clinical Data and Physician Engagement for Serranator Platform
15d ago
CAGEN
Serration Remodeling Therapy Data Highlight Potential Differentiation in PAD Treatment
PremiumPrivate Companies
Serration Remodeling Therapy Data Highlight Potential Differentiation in PAD Treatment
15d ago
CAGEN
Clinical Use Case Underscores Cagent Vascular’s Role in Peripheral Artery Disease Treatment
PremiumPrivate CompaniesClinical Use Case Underscores Cagent Vascular’s Role in Peripheral Artery Disease Treatment
16d ago
CAGEN
Physician Engagement Underscores Interest in Cagent Vascular’s SRT Technology
Premium
Private Companies
Physician Engagement Underscores Interest in Cagent Vascular’s SRT Technology
17d ago
CAGEN
Cagent Vascular Inc – Weekly Recap
Premium
Private Companies
Cagent Vascular Inc – Weekly Recap
22d ago
CAGEN
Cagent Vascular Showcases Serranator Outcomes and Standard-of-Care Ambitions
PremiumPrivate Companies
Cagent Vascular Showcases Serranator Outcomes and Standard-of-Care Ambitions
22d ago
CAGEN
Cagent Vascular Highlights Initial Clinical Use of Serranator Therapy
PremiumPrivate Companies
Cagent Vascular Highlights Initial Clinical Use of Serranator Therapy
23d ago
CAGEN
Clinical Case Use of Serranator Highlights Vascular Therapy Potential
PremiumPrivate Companies
Clinical Case Use of Serranator Highlights Vascular Therapy Potential
26d ago
CAGEN
Cagent Vascular Inc – Weekly Recap
PremiumPrivate Companies
Cagent Vascular Inc – Weekly Recap
1M ago
CAGEN
Serration Remodeling Therapy Positioned as Alternative to Standard Angioplasty
PremiumPrivate CompaniesSerration Remodeling Therapy Positioned as Alternative to Standard Angioplasty
1M ago
CAGEN
Cagent Vascular Refreshes Brand and Website to Highlight PAD and CLTI Focus
Premium
Private Companies
Cagent Vascular Refreshes Brand and Website to Highlight PAD and CLTI Focus
1M ago
CAGEN
Serration Remodeling Therapy Highlights Potential Differentiation in Calcified Vascular Lesions
Premium
Private Companies
Serration Remodeling Therapy Highlights Potential Differentiation in Calcified Vascular Lesions
1M ago
CAGEN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >